Global BioAccess Fund

Global BioAccess Fund provides early-stage capital to life sciences companies developing transformative medicines and devices. It focuses on oncology, cardiovascular, CNS, and rare diseases, supporting IND submissions and clinical trials. The firm is a venture capital investor with a team of scientists and pharma veterans using a data-driven approach. It aims to accelerate novel science and bring therapies to patients.